Sasaki H, Kawasaki T, Fujisawa M, Motooka Y, Asano T, Okumura M
Jpn Heart J. 1981 Jul;22(4):689-93. doi: 10.1536/ihj.22.689.
We studied the effect of angiotensin II analogue (AII-A) and angiotensin I converting enzyme inhibitor (SQ 14,225) on blood pressure and the renin-angiotensin-aldosterone system in a patient with pseudo-Bartter's syndrome, who was a 26-year-old unmarried Japanese woman taking furosemide surreptitiously. The intravenous infusion of AII-A decreased blood pressure from 85/35 to 68/28 mmHg. This decrease in blood pressure was associated with an increment of plasma renin activity (PRA) and a decrement of plasma aldosterone concentration (PAC). Similarly, SQ 14,225 given orally decreased blood pressure to the same extent. An increment of PRA and a decrement of PAC were also observed. These results suggest that the renin-angiotensin system plays a considerable role in maintaining blood pressure in pseudo-Bartter's syndrome. Again, attention has to be paid to the possibility of surreptitious use of diuretics in an adult patient with persistent hypokalemic alkalosis, hyperactivity of the renin-angiotensin-aldosterone system and angiotensin II insensitivity simulating "true" Bartter's syndrome.
我们研究了血管紧张素II类似物(AII-A)和血管紧张素I转换酶抑制剂(SQ 14,225)对一名假性巴特综合征患者血压及肾素-血管紧张素-醛固酮系统的影响。该患者为一名26岁未婚日本女性,偷偷服用速尿。静脉输注AII-A使血压从85/35 mmHg降至68/28 mmHg。血压下降与血浆肾素活性(PRA)升高及血浆醛固酮浓度(PAC)降低相关。同样,口服SQ 14,225使血压下降程度相同,同时也观察到PRA升高及PAC降低。这些结果表明,肾素-血管紧张素系统在维持假性巴特综合征患者血压方面发挥着重要作用。此外,对于成年患者出现持续性低钾性碱中毒、肾素-血管紧张素-醛固酮系统活性增高以及类似“真性”巴特综合征的血管紧张素II不敏感情况,必须注意其偷偷使用利尿剂的可能性。